Aligos Therapeutics, Inc. (ALGS)

NASDAQ: ALGS · USD

$4.87

+0.13 (+2.6%)· Recorded snapshot

Market cap	30.4M
Revenue (ttm)	31.5M
Net income (ttm)	-76M
EPS (ttm)	-$7.31
Shares out	6.2M
Volume	21,462
Beta	2.36

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 31.5M
Net income (ttm): -76M
EPS (ttm): -$7.31
Market cap: 30.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Conserver

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-113.6

P25 n/aP50 n/aP75 n/a

ROIC-68.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ALGS indicators

Market & fundamental data

Available fields

206

Groups with data

Currency

USD

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001799448
Company name	Aligos Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	01626L204
Earnings date	2026-11-09
Earnings time	bmo
Employees	82
Employees change	12
Employees growth	17.14%
Enterprise value	$3.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2018
Industry	Biotechnology
IPO date	2020-10-16
Is primary listing	Yes
Is SPAC	No
ISIN number	US01626L2043
Last 10-K release date	2026-03-05
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2024-08-19
Last stock split type	Reverse
Market cap	$30.4M
Market cap category	Nano-Cap
Next earnings date	2026-11-09
Options	No
Price	$4.87
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	ALGS
U.S. state	California
Website	https://www.aligos.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-150.33%
EV/Sales	0.09x
FCF / EV yield	-3,472.3%
FCF yield	-319.34%
Forward EV/Sales	0.41x
Forward P/S	4.49x
P/B ratio	0.93x
P/S ratio	0.94x
Price / tangible book value	0.93x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-250.63%
EBITDA margin	-247.21%
Gross margin	-180.4%
Operating margin	-250.63%
Pretax margin	-230.81%
Profit margin	-241.01%
Profit per employee	$-926,366
Revenue per employee	$384,366
ROA	-49.12%
ROA (5Y)	-44.04%
ROCE	-207.97%
ROE	-113.59%
ROE (5Y)	-166.44%
ROIC	-68.51%
SBC / revenue	17.78%
Tax / revenue	10.2%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	6
Net income growth quarters	1
Net income growth years	1
Revenue growth	893.01%
Revenue growth (Q)	2,778.55%
Revenue growth (QoQ)	881.55%
Revenue growth 3Y	22.25%
Revenue growth 5Y	66.61%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-355,000
Depreciation and amortization	$1.1M
EBIT	$-79M
EBITDA	$-77.9M
EPS	$-7.31
FCF per share	$-15.14
Financing cash flow	$228,000
Free cash flow	$-94.5M
Free cash flow minus SBC	$-100.1M
Gross profit	$-56.9M
Income taxes	$3.2M
Investing cash flow	$105.6M
Net borrowing	$-91,000
Net cash flow	$11.7M
Net income	$-76M
Operating cash flow minus SBC	$-99.8M
Operating income	$-79M
Revenue	$31.5M
Stock-based compensation	$5.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-16.05
Book value per share	$5.11
Debt / equity	0.11
Long-term assets	$4.2M
Long-term liabilities	$6.1M
Net cash (debt)	$26.9M
Net cash / market cap	90.8%
Net cash growth	-76.84%
Net debt / equity	-0.84
Piotroski F-Score	2
Property, plant and equipment	$3.4M
Shareholders' equity	$31.9M
Tangible book value	$31.9M
Tangible book value per share	$5.11
Total assets	$66.3M
Total cash	$30.4M
Total debt	$3.5M
Total liabilities	$34.4M
WACC	15.41%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.31
Current assets	$62.1M
Current liabilities	$28.3M
Current ratio	2.19
Net working capital	$6.6M
Quick ratio	2.05
Working capital	$33.8M
Working capital turnover	0.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-32.81%
Dividend yield	0%
Shareholder yield	-32.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$5.90
1D price change	2.64%
1M price change	-7.44%
1M total return	-7.44%
1W price change	1.39%
1W total return	1.39%
1Y price change	-47.8%
1Y return CAGR	-47.82%
1Y total return	-47.8%
20-day SMA	$5.16
200-day SMA	$6.28
3M price change	25%
3M total return	25%
3Y price change	-67.02%
3Y return CAGR	-30.9%
3Y total return	-67.02%
50-day SMA	$5.63
50-day SMA vs 200-day SMA	50under200
52-week high	$13.69
52-week high date	2025-12-15
52-week low	$3.98
52-week low date	2026-07-28
5Y price change	-98.74%
5Y return CAGR	-58.32%
5Y total return	-98.74%
6M price change	-20.68%
6M total return	-20.68%
All-time high	$937.75
All-time high date	2021-01-20
All-time low	$3.76
All-time low date	2025-04-11
Average true range (ATR)	$0.39
Average volume	32.5K
Beta (1Y)	1.53
Beta (2Y)	1.55
Beta (5Y)	2.36
Change from 52-week high	-64.46%
Change from 52-week low	22.24%
Change from all-time high	-99.46%
Change from all-time low	35.64%
Change from open	0%
Day's gap	2.64%
Dollar volume	$104,413
High price	$4.87
Low price	$4.87
Monthly RSI	38.66
Open price	$4.87
Premarket change	0%
Premarket close	$4.74
Premarket price	$4.74
Previous close	$4.74
Price vs 150-day SMA	-13.57%
Price vs 20-day SMA	-1.2%
Price vs 200-day SMA	-18.82%
Price vs 50-day SMA	-9.45%
Relative volume	0.66
Return from IPO open	-98.91%
Return from IPO price	-68.4%
RSI	47.34
Sharpe ratio	-0.35
Sharpe ratio (3Y)	0.14
Sharpe ratio (5Y)	-0.38
Sortino ratio	-0.47
Sortino ratio (3Y)	0.29
Sortino ratio (5Y)	-0.51
Volume	21.5K
Weekly RSI	43.9
YTD price change	-45.28%
YTD total return	-45.28%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.7M
Float percentage	58.96%
Shares change (QoQ)	0.27%
Shares change (YoY)	32.81%
Shares held by insiders	2.22%
Shares held by institutions	17.79%
Shares outstanding	6.2M
Short % of float	19.25%
Short % of shares	11.35%
Short ratio	14 days

Deeper analysis on ALGS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ALGS report

Is a complete ALGS research report available?

No complete published report is available for Aligos Therapeutics, Inc. (ALGS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Aligos Therapeutics, Inc. (ALGS)

Price

Financial snapshot

Fair-value bridge

Latest news · ALGS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ALGS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ALGS

Frequently asked questions